BridgeBio Pharma BBIO
NASDAQ BBIO
$67.25 +0.34 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Other Accumulated Expenses (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Other Accumulated Expenses of $192.19 million for Q2 2026, up 191.6% from $65.92 million a year earlier and up 41.8% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma posted Other Accumulated Expenses of $120.22 million, up 263.5% from FY2024.

  • Other Accumulated Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 55.2% (FY2020 to FY2025).
  • By year, Other Accumulated Expenses came in at $33.07 million in FY2024 (+86.2%), $17.76 million in FY2023 (+1.5%), $17.5 million in FY2022 (-42.2%) and $30.28 million in FY2021 (+126.8%).
  • The Q2 2026 figure ranks as the highest quarterly Other Accumulated Expenses in data going back to Q4 2018.
  • Year over year, Other Accumulated Expenses has now increased in each of the last seven quarters, with growth averaging 306.4% over the last seven quarters.
  • The high point for year-over-year Other Accumulated Expenses in five years was Q3 2025 (growth of 615.8%); the low point was Q1 2024 (a decline of 51.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $135.51 million (Q1 2026), $120.22 million (Q4 2025) and $92.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 BridgeBio Pharma 13.13 Bn 10.25 Bn 228.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 192.19 Mn
Mar 31, 2026 135.51 Mn
Dec 31, 2025 120.22 Mn
Sep 30, 2025 92.74 Mn
Jun 30, 2025 65.92 Mn
Mar 31, 2025 40.67 Mn
Dec 31, 2024 33.07 Mn
Sep 30, 2024 12.96 Mn
Jun 30, 2024 11.35 Mn
Mar 31, 2024 10.88 Mn
Dec 31, 2023 17.76 Mn
Jun 30, 2023 17.52 Mn
Mar 31, 2023 22.22 Mn
Dec 31, 2022 17.50 Mn
Sep 30, 2022 23.84 Mn
Jun 30, 2022 31.98 Mn
Mar 31, 2022 24.78 Mn
Dec 31, 2021 30.28 Mn
Sep 30, 2021 14.61 Mn
Jun 30, 2021 21.18 Mn
API Access

BridgeBio Pharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BBIO&period=max&api_key=YOUR_API_KEY